Horizon Pharma (HZNP) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Brean Capital Remains Bullish on Horizon Pharma (HZNP) Following 2Q Beat
August 10, 2015 6:51 AM EDTBrean Capital reiterated a Buy rating and $40 price target on Horizon Pharma (NASDAQ: HZNP) following the release of its 2Q15 earnings results. revenue was $172.8 million beating consensus estimates of $156.4. Non-GAAP EPS was $0.39 beating consensus' $0.32.
Analyst Difei Yang commented, "Given the pre-announcement of... More
Depomed (DEPO) Sends Letter to Horizon Pharma (HZNP); Will be Open to 'Compelling Proposal'
August 7, 2015 6:32 AM EDTDepomed (NASDAQ: DEPO) has sent the following letter to Horizon Pharma plc (NASDAQ: HZNP) ("Horizon"):
August 7, 2015
Timothy P. Walbert Chairman of the Board, President and Chief Executive OfficerHorizon Pharma plcConnaught House, 1st Floor, 1 Burlington Road Dublin 4, Ireland
Dear Tim,
In our conversation late last week, you stated that Horizon was prepared to increase its proposal and to... More
